PSTG (Everpure) — Earnings Review Q4 FY2026

Date: 2026-04-06 Quarter: Q4 FY2026 (DB label: Q1_FY26, ended February 1, 2026) Price: ~62|Marketcap22.4B | Run-rate P/S: 5.3x | Run-rate Non-GAAP P/E: ~23x Company: Everpure (rebranded from Pure Storage, March 5, 2026; NYSE: PSTG)


Verdict

Everpure just printed the most compelling leading indicator divergence I've seen in an infrastructure company in two years. RPO surged $800M in a single quarter to $3.7B (+40% YoY) while revenue grew 20.4% — that 20pp gap is textbook alpha. First billion-dollar quarter, beat-and-raise, Non-GAAP operating margin at ATH (21.3%), and FY27 guide implies further acceleration. The market is pricing this like a 14% grower at ~23x run-rate Non-GAAP P/E. It's wrong.

GM compression of 2.7pp is real and I take it seriously — the CFO's "nonexistent visibility" on NAND costs is honest but uncomfortable. But operating leverage absorbed the GM hit and still expanded operating margin. The 20% price increase (effective Feb 9) hasn't even flowed yet. This is a GARP setup hiding in plain sight.

I held PSTG as a small position back in 2023, watching for Meta RSC and early Gen AI catalysts. The company has metamorphosed. From a "low eight-figure Gen AI deal" that excited me in September 2023 to a $1.06B quarter driven by AI infrastructure demand — that's the thesis playing out at scale. I should have held a larger position.

Action: Initiate position. Add on Q1 FY27 confirmation.


The Numbers

Revenue (16 Quarters)

| | Q2 FY22 | Q3 FY22 | Q4 FY22 | Q1 FY23 | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | | | Jun-22 | Sep-22 | Dec-22 | Mar-23 | Jun-23 | Sep-23 | Dec-23 | Mar-24 | Jun-24 | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| | Rev ($m) | 620 | 647 | 676 | 810 | 589 | 689 | 763 | 790 | 694 | 764 | 831 | 880 | 779 | 861 | 965 | 1,059 | | QoQ % | — | 4.3 | 4.5 | 19.9 | -27.3 | 16.9 | 10.8 | 3.5 | -12.2 | 10.1 | 8.8 | 5.9 | -11.5 | 10.6 | 12.0 | 9.8 | | YoY % | — | — | — | — | -5.0 | 6.5 | 12.8 | -2.5 | 17.7 | 10.9 | 9.0 | 11.4 | 12.3 | 12.7 | 16.1 | 20.4 | | Beat % | — | — | — | — | — | — | — | — | — | — | — | — | — | +1.9 | +1.0 | +2.8 |

The QoQ Grid (Years Across, Quarters Down)

This is the grid that matters. PSTG's fiscal year ends in early February, so Q1 in the DB (calendar Mar) = PSTG's fiscal Q4. Seasonally the strongest quarter.

Quarter (Cal.) FY23 FY24 FY25 FY26 Trend
Q1 (Mar) — Year-end +19.9% +3.5% +5.9% +9.8% Accelerating 3 years running
Q2 (Jun) — Seasonal trough -27.3% -12.2% -11.5% Guide: -5.6% Improving dramatically
Q3 (Sep) — Recovery +16.9% +10.1% +10.6% Stable
Q4 (Dec) — Build +10.8% +8.8% +12.0% Accelerating

The Q1 (year-end) QoQ: 3.5% → 5.9% → 9.8%. That's acceleration within the same seasonal quarter across three years. Nuf said.

The Q2 FY26 guide ($1,000M midpoint) implies only -5.6% QoQ decline vs historical -12% to -27%. If backlog is dampening seasonality, that's a structural improvement in revenue linearity. Guided Q2 implies +28.5% YoY — acceleration from the 20.4% just reported.

YoY Acceleration — Same-Quarter View

Quarter (Cal.) FY24 YoY FY25 YoY FY26 YoY Trend
Q1 (Mar) -2.5% +11.4% +20.4% Accelerating
Q2 (Jun) +17.7% +12.3% +28.5% (guide) Accelerating
Q3 (Sep) +10.9% +12.7%
Q4 (Dec) +9.0% +16.1%

Five consecutive quarters of YoY acceleration: 11.4% → 12.3% → 12.7% → 16.1% → 20.4%. This is not a blip. This is a demand inflection.

Margins

| | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | | | Jun-25 | Sep-25 | Dec-25 | Mar-26 | |---|---|---|---|---| | GM [GAAP] | 68.9% | 70.2% | 72.3% | 69.9% | | GM [Non-GAAP] | 70.9% | 72.1% | 74.1% | 71.4% | | Op Mg [Non-GAAP] | 10.6% | 15.1% | 20.3% | 21.3% (ATH) | | Net Mg [GAAP] | -1.8% | 5.5% | 5.7% | 9.5% | | FCF Mg | 27.2% | 17.4% | 5.5% | 19.0% | | EPS [Non-GAAP] | $0.29 | $0.43 | 0.58|**0.69** |

The margin story: Non-GAAP GM compressed 2.7pp QoQ (74.1% → 71.4%) from NAND cost inflation. That is the bad news. But Non-GAAP operating margin hit ATH at 21.3% regardless. Operating leverage absorbed the GM hit — OpEx discipline is excellent. This is what good management looks like under cost pressure.

Non-GAAP EPS trajectory: $0.29 → $0.43 → $0.58 → $0.69 across four quarters. That's a 138% acceleration from the start of the tracking period.

Cash Flow & Capital

Metric Q1 FY26 FY26 Full Year
FCF $201.4M (19.0%) $615.7M (16.8%)
Op Cash Flow $268.0M $880.1M
SBC $133.5M (12.6%) $481.7M (13.2%)
Buybacks $127.2M $342.6M
Cash + Securities $1,547.3M
Debt $0

→ FCF recovered to 201MafterseasonalQ4trough(52.6M). FY26 FCF of $616M with $343M returned via buybacks = 56% of FCF returned. Net cash $1.55B, zero debt. Fortress balance sheet.

→ SBC at 12.6% of revenue is tracking revenue growth. Not exceptional, not alarming. Dilution is modest: ~1-2% annual net after buybacks.


Leading Indicators — The Real Story

RPO Divergence (The Alpha Signal)

Quarter RPO ($B) RPO YoY Revenue YoY Gap (pp)
Q2 FY25 2.7 ~+17% +12.3% +5
Q3 FY25 2.8 ~+22% +12.7% +9
Q4 FY25 2.9 ~+24% +16.1% +8
Q1 FY26 3.7 +40% +20.4% +20

RPO growing at 2x revenue growth rate. Gap widened from 5pp to 20pp in four quarters. The $800M QoQ RPO add — vs a prior run-rate of $100M/Q — is an 8x step-change. This is either a massive hyperscaler commitment or broad enterprise demand inflection (likely both).

Per my analytical framework: "When revenue looks 'steady' but 2+ leading indicators show acceleration for 2+ quarters, the market is likely underpricing future growth." We have three diverging indicators:

  1. RPO +40% vs revenue +20% (strongest signal)
  2. Product revenue +25% vs blended +20%
  3. $5M+ deals +80% YoY (enterprise commitment depth)

That's textbook. Revenue should track closer to RPO growth within 2-4 quarters → implies 25-30%+ growth trajectory by mid-FY27.

Subscription ARR — Mild Concern, Not a Red Flag

Quarter Sub ARR ($B) Growth
Q2 FY25 1.7 ~18%
Q3 FY25 1.8 ~18%
Q4 FY25 1.8 ~17%
Q1 FY26 1.9 ~16%

ARR decelerating from 18% to 16%. But this is base-rate compression at scale ($1.9B ARR), not a demand problem. Product revenue growing 25% shows customers are buying more hardware upfront (AI infrastructure deployments), with subscription revenue following. RPO at $3.7B backstops future subscription conversion.

Segment Mix

Q2 FY25 Q3 FY25 Q4 FY25 Q1 FY26
Product Rev ($m) 372 446 535 619 (+25% YoY)
Sub Services ($m) 406 415 430 440 (+14% YoY)
Product % of Total 47.8% 51.9% 55.4% 58.4%

Product now 58% of revenue, up from 48% a year ago. This creates a near-term GM headwind (product GM ~65-70% vs subscription GM higher). But if hyperscaler product margins are 75-85% as management claims, the mix shift becomes margin-accretive at scale. This is the key Q1-Q2 FY27 watch item.


Conference Call — Key Takeaways

CEO Giancarlo: Positioned the company as a "data intelligence provider," not a storage company. This framing is strategically important — it justifies the rebrand, the 1touch acquisition, and the pricing power narrative. He has 8+ years as CEO and the Cisco CTO pedigree. I trust this CEO.

CFO Robbiati: The most important quote of the quarter: "Visibility is just nonexistent" regarding NAND/component pricing. This is unusually candid during a beat-and-raise quarter. A weaker management team would have buried this. Instead, Robbiati paired it with a 20% price increase — acknowledging the problem and acting on it simultaneously. This is CFO credibility at its finest. As a CFO myself, I respect the willingness to flag uncertainty when the numbers are good. That's when you earn trust.

CTO Rob Lee on FlashBlade//EXA: "A GPU cloud customer that conducted performance testing, shifted away from an alternate vendor, and placed an order quickly." Switcher wins are the strongest PMF signal. Not installed-base lock-in — competitive displacement.


Guidance — Conservative and Beatable

Metric FY27 Guide Implied Growth My Assessment
Q1 FY27 Revenue 990M1,010M +28.5% YoY Conservative. Old-price clearing depresses near-term. Beat likely.
FY27 Revenue 4, 300M4,400M +17-20% YoY Very conservative against $3.7B RPO growing 40%.
FY27 Non-GAAP Op Income 780M820M +23-29% YoY First explicit op income guide. Signals margin confidence.
FY27 Non-GAAP Op Margin ~18.3% implied vs FY26 17.3% Includes 1touch dilution (~1.5%). Underlying expansion stronger.

The Q1 FY27 guide is sandbagged. Management explicitly told us old-price proposals will clear in Q1, depressing product margins to the "lower end of 65-70%." The 20% price increase (effective Feb 9, 2026) flows primarily in Q2+ FY27. This creates a predictable margin recovery setup for Q2-Q4 FY27.

The FY27 revenue guide is beatable. $4,350M midpoint against $3.7B RPO growing 40%. Management has beaten every quarterly and annual guide across FY26 — beat magnitude widening from $16M to $29M. Conservative guidance is their pattern. If I assume 2-3% quarterly beats (consistent with track record), FY27 revenue could be $4,500M+.


Valuation — Market Is Mispricing This

Correction to Atlas baseline: Atlas calculated run-rate Non-GAAP P/E as 84.6x, but that used a single quarter's earnings against full market cap without annualising. The correct calculation:

Metric Calculation Value
Market cap ~$62 x 361.9M shares ~$22.4B
Run-rate revenue $1,058.9M x 4 $4,235.6M
Run-rate Non-GAAP NI $238.8M x 4 $955.2M
Run-rate P/S $22.4B / $4.2B 5.3x
Run-rate Non-GAAP P/E $22.4B / $955M ~23x
FY26 Non-GAAP P/E $62 / $1.99 FY26 EPS ~31x
FY27 fwd Non-GAAP P/E ~22.4B850M est. NI ~26x
PEG (P/S / growth) 5.3x / 20.4% 0.26x
Net cash $1,547M
EV ~$20.9B
Rule of 40 20.4% + 19.0% 39.4

23x run-rate Non-GAAP P/E for a company growing 20%+ and accelerating. PEG of 0.26x. Zero debt. $1.55B net cash. 19 analysts with average Buy rating and $91 target (47% upside from current price).

→ Storage peer median: NetApp trades at 18-22x P/E on 3-5% growth. PSTG trades at 23x P/E on 20% growth with 40% RPO acceleration. The market is applying a storage discount to what is becoming an AI infrastructure platform.

→ If growth sustains at 20%+ for 2-3 quarters (RPO says it will), multiple expansion toward 30-35x Non-GAAP P/E is justified → $80-90 price target. That aligns with analyst consensus of $91.


Prior Beliefs / Updated Beliefs

My History with PSTG

I owned a small position in PSTG in 2023, focused on two catalysts: (1) Meta RSC follow-on orders, and (2) early Gen AI deal traction. At the time (September 2023), the most exciting data point was a "low eight-figure" Gen AI deal. Revenue was growing 7-13% YoY. I exited the position — likely too early — as growth wasn't meeting my threshold.

What's changed: Revenue acceleration from 11% to 20% over five quarters, RPO surging to $3.7B (+40%), first billion-dollar quarter, AI infrastructure becoming the primary growth driver, hyperscaler channel opening at 75-85% GM, and a management team that has earned credibility through consistent beat-and-raise execution.

Updated Beliefs

Metric Expected (Pre-Q4) Actual Assessment
Revenue ~$1,030M (guide mid) $1,058.9M (+2.8% beat) Strong beat. First $1B quarter.
Revenue YoY ~17-18% 20.4% Better than expected. 5th consecutive acceleration.
RPO ~$3.0B (+24%) $3.7B (+40%) Significantly exceeded. $800M QoQ step-change. The headline.
Non-GAAP GM ~73-74% 71.4% Below expectations. NAND cost pressure real.
Non-GAAP Op Mg ~20% 21.3% (ATH) Strong. Leverage absorbed GM hit.
FY27 Guide ~$4.2B (+15%) $4.35B (+18% mid) Beat expectations. Conservative and beatable.

Delta: RPO step-change was the biggest positive surprise; GM compression was the biggest negative. Net assessment: strongly positive. The RPO divergence signals 2-4 quarters of revenue acceleration ahead. GM compression is manageable with pricing action and likely temporary through Q1 FY27.


Risks

  1. NAND cost uncertainty — CFO says visibility is "nonexistent." If NAND spikes further, even 20% price increase may not fully offset. Q1 FY27 product margins guided to lower end of 65-70%. Probability: Medium. Impact: Medium. Manageable because operating leverage provides a buffer and pricing flows Q2+.

  2. Product mix shift — Product now 58% of revenue at lower margins. If hyperscaler 75-85% GM doesn't materialise, blended margins could compress structurally. Probability: Low-Medium. Impact: High. Watch the hyperscaler margin disclosure in FY27.

  3. Employee sentiment deterioration — Glassdoor 3.7/5 (down 8%), stealthy layoffs (~300+), CMO instability. Not in financials yet. Probability: Medium. Impact: Low-Medium. Lagging indicator, but worth watching.

  4. 1touch integration — 1.5% op income dilution in FY27, 24-month accretion timeline. If integration stumbles, this becomes a distraction and profit headwind. Probability: Low. Impact: Low. Small relative to overall business.

  5. Valuation re-rate risk — If growth disappoints in Q1-Q2 FY27 (particularly if revenue doesn't track RPO), the storage discount could reassert. Probability: Low (RPO backstops). Impact: Medium.


Catalysts to Watch

Event Timing What I'm Watching
Q1 FY27 results ~June 2026 Does revenue beat $1,000M guide? RPO conversion? Product margin in 65-70%?
Q2 FY27 results ~Sep 2026 Does 20% price increase show in GM recovery to 73%+? Growth sustain 20%+?
Hyperscaler volume FY27 Quantification of "low double-digit exabytes." Margin validation.
Market share Q3-Q4 FY27 IDC projects #3 behind NetApp in "2-3 quarters." Would trigger re-rating.
1touch integration Ongoing Any customer wins or product announcements validating data intelligence thesis.

Thesis

Everpure is a GARP opportunity in AI infrastructure with structural growth reacceleration, operating leverage, and valuation discount.

Three pillars:

  1. Revenue acceleration driven by AI demand — five consecutive quarters of YoY acceleration, RPO at +40% signals continuation
  2. Margin expansion — 20% price increase + hyperscaler channel at 75-85% GM + operating leverage (21.3% Non-GAAP op margin ATH)
  3. Valuation discount — market prices this as a storage hardware company (~23x P/E) when leading indicators say it's an AI infrastructure platform accelerating toward 25-30% growth

Thesis status: Intact — Strengthening.

Conviction: 3.5/5 — I agree with Atlas's assessment that revenue below 30% caps conviction. But the RPO divergence, beat-and-raise cadence, and valuation discount make this a compelling risk/reward. If Q1 FY27 revenue exceeds $1,010M (beats guide) and YoY acceleration continues above 25%, I'd bump conviction to 4/5 and increase position size.


-wsm

(Initiating position in PSTG. Target 3-5% starting allocation.)


Sources:


WSM analysis complete. Filed: 2026-04-06.